FULL PAPER
Chloro-[1-butyl-3-(1-phenylethyl)phenanthro[9,10-d]imidazolin-2- troscopy. 13C{1H} NMR (101 MHz, CDCl3): δ = 184.8 (NCN),
ylidene]copper(I) (3a): 1-Butyl-3-(1-phenylethyl)phenanthro[9,10-
d]imidazolium chloride (2a) (920 mg, 2.22 mmol) were mixed with
Cu2O (320 mg, 2.24 mmol), suspended in dry 1,4-dioxane (20 mL)
and stirred for 16 h at reflux. After cooling, the solvent was evapo-
rated, the residue suspended in dichloromethane (20 mL) and fil-
tered via cannula. The solution was concentrated to a quarter of
its volume by evaporation and the product precipitated as a white
powder by addition of diethyl ether (10 mL). After filtration the
product was dried under reduced pressure to obtain a white pow-
167.1 (C=O), 129.6, 127.9, 126.8, 126.6, 124.4, 120.7 (ArC), 62.5
(OCH2), 14.0 (CH2CH3) ppm. C27H24ClCuN2O2 (507.49): calcd. C
63.90, H 4.77, N 5.52; found C 64.34, H 5.01, N 5.36.
Chloro(η4-1,5-cod)[1-butyl-3-(1-phenylethyl)phenanthro[9,10-d]-
imidazolin-2-ylidene]rhodium(I) (4Cl): [RhCl(cod)]2 (43 mg,
87 μmol) and copper complex 3a (83 mg, 174 μmol) were dissolved
in acetonitrile (2 mL) and stirred for approximately 1 h till the
product precipitated as a yellow solid. The mixture was filtered via
cannula and the product washed twice with 1 mL of acetonitrile
each. After drying under reduced pressure 74 mg (68%) of 4Cl were
1
der, yield 900 mg (85%). H NMR (400 MHz, CDCl3): δ = 8.77–
3
8.86 (m, 2 H, ArH), 8.38 (d, J = 7.8 Hz, 1 H, ArH), 8.20 (br. s, 1
1
3
obtained. H NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 8.0 Hz,
H, ArH), 7.71–7.81 (m, 2 H, ArH), 7.65 (br. t, 1 H, ArH), 7.55 (br.
s, 1 H, ArH), 7.30–7.44 (m, 5 H, ArH), 6.71 (br. s, 1 H, NCH),
5.07 (t, 3J = 7.4 Hz, 2 H, NCH2), 2.35 (br. s, 3 H, NCHCH3), 2.01–
2.11 (m, 2 H, NCH2CH2), 1.52–1.64 (m, 2 H, CH2CH3), 1.02 (t,
3J = 7.3 Hz, 3 H, CH2CH3) ppm. 13C NMR spectra showed only
a few broadened signals. Some could be assigned with HSQC and
HMBC spectroscopy. 13C{1H} NMR (101 MHz, CDCl3): δ = 182.9
(NCN), 139.7, 129.3, 127.9, 126.8, 124.3, 121.6 (ArC), 53.2
(NCH2), 32.7 (NCH2CH2), 19.8 (CH2CH3), 13.6 (CH2CH3) ppm.
C27H26ClCuN2 (477.51): calcd. C 67.91, H 5.49, N 5.87; found C
67.72, H 5.28, N 5.82.
3
3
1 H, ArH), 8.70 (d, J = 8.4 Hz, 1 H, ArH), 8.51 (q, J = 7.1 Hz,
1 H, NCH), 8.42 (d, J = 7.8 Hz, 1 H, ArH), 7.72–7.77 (m, 1 H,
3
ArH), 7.64–7.70 (m, 2 H, ArH), 7.44–7.49 (m, 1 H, ArH), 7.26–
7.36 (m, 5 H, ArH), 7.19–7.25 (m, 1 H, ArH), 5.91 (ddd, 2J = 13.8,
3J = 12.6, 5.1 Hz, 1 H, NCH2CH2), 5.38 (ddd, 2J = 13.9, 3J = 12.4,
4.3 Hz, 1 H, NCH2CH2), 5.17–5.25 (m, 1 H, CHcod), 5.03–5.10 (m,
1 H, CHcod), 3.47–3.56 (m, 2 H, CHcod), 2.35–2.59 (m, 3 H), 2.25
(d, 3J = 7.2 Hz, 3 H, NCHCH3), 2.15–2.26 (m, 1 H), 1.69–2.12 (m,
8 H), 1.21 (t, 3J = 7.4 Hz, 3 H, CH2CH3) ppm. 13C{1H} NMR
1
(101 MHz, CDCl3): δ = 193.0 (d, JRhC = 51.6 Hz, NCN), 141.7,
129.0, 128.7, 128.7, 128.4, 128.2, 127.3, 127.0, 126.2, 125.8, 125.5,
1
Chloro[1-benzyl-3-(1-phenylethyl)phenanthro[9,10-d]imidazolin-2-
ylidene]copper(I) (3b): 1-Benzyl-3-(1-phenylethyl)phenanthro[9,10-
d]imidazolium chloride (2b) (740 mg, 1.65 mmol) was mixed with
Cu2O (236 mg, 1.65 mmol), suspended in dry 1,4-dioxane (20 mL)
and stirred for 16 h at reflux. After cooling, the solvent was evapo-
rated, the residue suspended in dichloromethane (20 mL) and fil-
tered via cannula. The solution was concentrated to a quarter of
its volume by evaporation and the product precipitated as a white
powder by addition of diethyl ether (10 mL). After filtration the
product was dried under reduced pressure to obtain 3b with
0.4 equiv. CH2Cl2, yield 670 mg (75%). The product was used with-
out further purification and a small amount was washed with
dichloromethane for elemental analysis and NMR measurements.
125.3, 125.2, 124.0, 123.4, 121.7, 121.5, 120.7 (ArC), 99.1 (d, J =
6.8 Hz, CHcod), 98.5 (d, 1J = 6.9 Hz, CHcod), 69.5 (d, 1J = 14.2 Hz,
CHcod), 68.5 (d, J = 14.5 Hz, CHcod), 62.3 (NCH), 52.0 (NCH2),
33.2, 32.3, 31.6, 29.6, 28.1, 20.4, 18.9 (CHCH3 ), 13.8
(CH2CH3) ppm. C35H38ClN2Rh (625.05): calcd. C 67.25, H 6.13,
N 4.48; found C 67.25, H 6.00, N 4.66.
Chloro(η4-1,5-cod)[1-benzyl-3-(1-phenylethyl)phenanthro[9,10-d]-
imidazolin-2-ylidene]rhodium(I) (5Cl): [RhCl(cod)]2 (23 mg,
47 μmol) and copper complex 3b (52 mg, 95 μmol) were dissolved
in acetonitrile (1 mL) and stirred until the product precipitated as a
yellow solid. The mixture was filtered via cannula and the product
washed with acetonitrile (0.5 mL). After drying under reduced
1
3
1H NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 8.3 Hz, 1 H, ArH),
pressure 51 mg (80%) of 5Cl were obtained. H NMR (400 MHz,
3
3
CDCl3): δ = 8.67–8.75 (m, 2 H, ArH), 8.61 (q, J = 7.2 Hz, 1 H,
8.75 (d, J = 8.3 Hz, 1 H, ArH), 8.24 (br. s, 1 H, ArH), 7.47–7.70
3
3
3
NCH), 8.13 (d, J = 8.4 Hz, 1 H, ArH), 7.74 (d, J = 8.2 Hz, 1 H,
ArH), 7.70 (d, 2J = 17.1 Hz, 1 H, NCH2), 7.22–7.59 (m, 14 H,
ArH), 6.40 (d, 2J = 17.7 Hz, 1 H, NCH2), 5.11–5.21 (m, 1 H,
CHcod), 5.00–5.08 (m, 1 H, CHcod), 3.47–3.55 (m, 1 H, CHcod),
3.24–3.33 (m, 1 H, CHcod), 2.27–2.40 [m, 1 H, (CH2)cod], 2.30 (d,
3J = 7.2 Hz, 3 H, CH3), 2.12–2.24 [m, 1 H, (CH2)cod], 1.52–1.95
[m, 6 H, (CH2)cod] ppm. 13C{1H} NMR (101 MHz, CDCl3): δ =
194.6 (d, 1JRhC = 51.9 Hz, NCN), 141.6, 137.4, 129.9, 129.1, 129.1,
128.7, 128.6, 128.1, 127.5, 127.2, 127.1, 126.3, 125.9, 125.7, 125.4,
(m, 4 H, ArH), 7.23–7.46 (m, 8 H, ArH), 7.13 (d, J = 7.1 Hz, 2
H, ArH), 6.81 (br. s, 1 H, NCH), 6.32 (s, 2 H, NCH2), 2.42 (br. s,
3 H, NCHCH3) ppm. 13C NMR spectra showed only a few broad-
ened signals. Some could be assigned with HSQC and HMBC spec-
troscopy at 50 °C. 13C{1H} NMR (101 MHz, CDCl3): δ = 184.4
(NCN), 139.8, 135.3, 129.5, 128.4, 127.8, 126.8, 125.8, 123.7, 122.1,
1 2 1 . 3 ( A r C ) , 5 9 . 7 ( N C H ) , 5 6 . 8 ( N C H 2 ) p p m .
C30H24ClCuN2·0.4CH2Cl2 (545.50): calcd. C 66.93, H 4.58, N 5.14;
found C 66.73, H 4.31, N 5.18.
3
125.1, 123.6, 123.4, 122.1, 121.2, 120.7 (ArC), 99.4 (d, J = 6.8 Hz,
Chloro[1-ethoxycarbonylmethyl-3-(1-phenylethyl)phenanthro[9,10-
d]imidazolin-2-ylidene]copper(I) (3c): Compound 2c (450 mg,
1.01 mmol) was mixed with Cu2O (145 mg, 1.01 mmol), suspended
in dry 1,4-dioxane (15 mL) and stirred for 18 h at reflux. After
cooling, the solvent was evaporated, the residue suspended in
dichloromethane (20 mL) and filtered via cannula. The solvent was
evaporated and the residue washed with petroleum ether (10 mL).
After filtration the product was dried under reduced pressure to
obtain 3c as an off-white powder, yield 380 mg (74%). The product
was used without further purification. 1H NMR (400 MHz,
CDCl3): δ = 8.78–8.85 (m, 2 H, ArH), 8.27 (br. s, 1 H, ArH), 8.08–
CHcod), 98.5 (d, 3J = 6.9 Hz, CHcod), 69.5 (d, 3J = 14.1 Hz, CHcod),
69.4 (d, 3J = 14.3 Hz, CHcod), 62.4 (NCH), 55.5 (NCH2), 32.9
[(CH2)cod], 32.0 [(CH2)cod], 29.1 [(CH2)cod], 28.2 [(CH2)cod], 18.7
(CH3) ppm. C38H36ClN2Rh·0.33MeCN (672.61): calcd. C 69.03, H
5.54, N 4.85; found C 69.01, H 5.81, N 4.79.
Chloro(η4-1,5-cod)[1-ethoxycarbonylmethyl-3-(1-phenylethyl)-
phenanthro[9,10-d]imidazolin-2-ylidene]rhodium(I) (6Cl):
[RhCl(cod)]2 (23 mg, 47 μmol) and copper complex 3c (50 mg,
99 μmol) were dissolved in chloroform (2 mL), whereby a precipi-
tation of copper(I)chloride occurred. A saturated aqueous CaCl2
solution (2 mL) were added and the mixture stirred vigorously for
8.14 (m, 1 H, ArH), 7.52–7.76 (m, 4 H, ArH), 7.32–7.46 (m, 5 H,
3
ArH), 6.72 (br. s, 1 H, NCH), 5.84 (s, 2 H, NCH2), 4.29 (q, J = a few minutes. The organic layer was separated and the aqueous
7.1 Hz, 2 H, OCH2), 2.38 (br., 3 H, NCHCH3), 1.28 (t, 3J = 7.1 Hz,
3 H, OCH2CH3) ppm. 13C NMR spectra showed only a few broad-
ened signals. Some could be assigned with HSQC and HMBC spec-
phase extracted with CHCl3 (1 mL). The organic phases were com-
bined and again washed with the saturated CaCl2 solution (2 mL).
The organic phase was dried with MgSO4 and passed through a
Eur. J. Inorg. Chem. 2014, 1389–1393
1392
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim